Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08KMU
|
|||
| Drug Name |
Gca-186
|
|||
| Synonyms |
gca-186; I-EBU-dM; 6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL; CHEMBL319139; CHEBI:42702; 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil; 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-(1-methylethyl)uracil; 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-(propan-2-yl)pyrimidine-2,4(1H,3H)-dione; 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione; AC1L1FZB; CTK6G4092; BDBM50032238; DB07820; 6-(3,5-Dimethylbenzyl)-1-(ethoxymethyl])-5-isopropyluracil
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Clinical trial | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H26N2O3
|
|||
| Canonical SMILES |
CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC(=CC(=C2)C)C
|
|||
| InChI |
1S/C19H26N2O3/c1-6-24-11-21-16(10-15-8-13(4)7-14(5)9-15)17(12(2)3)18(22)20-19(21)23/h7-9,12H,6,10-11H2,1-5H3,(H,20,22,23)
|
|||
| InChIKey |
NVGVZWUORYLPAL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 149950-61-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:42702
|
|||
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.